Kennedy Capital Management, Inc. Catalent, Inc. Transaction History

Kennedy Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $2.07 Million - $3.38 Million	45,572 New	45,572 $2.99 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $369,815 - $483,686	-4,241 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $2.91 Million - $3.85 Million	-30,904 Reduced 87.93%	4,241 $470,000
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $142,766 - $166,049	-1,194 Reduced 3.29%	35,145 $4.5 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $220,305 - $287,262	-2,018 Reduced 5.26%	36,339 $4.84 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $166,765 - $192,276	1,662 Added 4.53%	38,357 $4.15 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $3.72 Million - $4.6 Million	36,695 New	36,695 $3.86 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.